Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in Cyprus has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Cyprus have shifted towards a more health-conscious lifestyle. As people become more aware of the importance of self-care and managing pain, the demand for analgesics has increased. Customers are looking for effective and safe pain relief options, and they often turn to pharmacies for advice and recommendations. This has led to a rise in sales of analgesics in pharmacies. Trends in the market also play a role in the growth of the Analgesics (Pharmacies) market in Cyprus. One significant trend is the increasing availability of over-the-counter analgesics in pharmacies. This allows customers to easily access pain relief medication without the need for a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers. Another trend in the market is the growing demand for natural and alternative pain relief options. Many consumers are seeking out products that are perceived to be more natural and have fewer side effects. This has led to an increase in the sales of herbal or homeopathic analgesics in pharmacies. Customers are also interested in complementary therapies such as acupuncture or chiropractic care, which can be found in some pharmacies. Local special circumstances in Cyprus have also influenced the development of the Analgesics (Pharmacies) market. The country has a high prevalence of chronic pain conditions, such as arthritis, which has increased the demand for analgesics. Additionally, the aging population in Cyprus has contributed to the growth of the market, as older individuals are more likely to experience pain and seek pain relief options. Underlying macroeconomic factors have also played a role in the growth of the Analgesics (Pharmacies) market in Cyprus. The country has experienced economic stability in recent years, which has led to increased consumer spending power. This has allowed consumers to prioritize their health and well-being, including purchasing analgesics from pharmacies. In conclusion, the Analgesics (Pharmacies) market in Cyprus has been developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for pain relief options, the availability of over-the-counter analgesics, the demand for natural and alternative products, the prevalence of chronic pain conditions, the aging population, and economic stability have all contributed to the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
